MissionIR Articles

OvaScience, Inc. (NASDAQ: OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because it believes women deserve more options.…

Orient Paper, Inc. (NYSE: ONP) is a leading paper manufacturer in North China. Using recycled paper as its primary raw material (with the exception of its digital photo paper and tissue paper products), Orient Paper produces…

Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. From the company’s inception, Oramed…

Opexa Therapeutics, Inc. (NASDAQ: OPXA) is a biotechnology company developing personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases, such as neuromyelitisoptica (NMO). These therapies…

Oncothyreon, Inc. (NASDAQ: ONTY) is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. Recognizing that cancer is a complex disease involving changes to…

Established in 2011, OncoSec Medical Incorporated (NASDAQ: ONCS) is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary technology, the company means…

Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of…

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) has designed a humanitarian program to respond to unexpected disasters—floods, earthquakes, tsunamis, hurricanes, epidemics and even man-made calamities—by providing product (such as food or medical assistance) to these victims.…

Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a clinical stage biopharmaceutical companyfocused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease. Ocera’s lead program, OCR-002 (ornithine phenylacetate) is an…

Ocean Power Technologies, Inc. (NASDAQ: OPTT) is a pioneer in renewable wave-energy technology that converts ocean wave energy into electricity. OPT’s proprietary PowerBuoy technology is based on a modular design and has undergone periodic ocean…

Novatel Wireless, Inc. (NASDAQ: NVTL) delivers intelligent wireless solutions that simplify the Internet of Things (IoT). The company has invented and reinvented ways in which the world stays connected and accesses information. With multiple first-to-market…

NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. NovaBay has two distinct product categories:…

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more efficiently and cost-effectively than current treatments, and without the side effects of chemotherapy drugs. The…

Boulder, Colorado-based Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is discovering solutions for cystic fibrosis. The company is developing a class of disease-modifying therapies designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell-signaling effects that…

NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai…

NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxaminedihydrochloride), a late stage…

NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called “nanoviricides.” So far, virus-specific nanoviricide drug candidates against five commercially important viral…

Nano Dimension (OTC: NNDMY) was founded in 2012 and focuses on the research and development of advanced 3D electronics printing, including a printer for printing PCBs (printed circuit boards), and the development of nanotechnology- based…

Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company, is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of toll-like immune receptor activators has applications in radiation…